Zobrazeno 1 - 10
of 594
pro vyhledávání: '"R. Paridaens"'
Publikováno v:
Cancer Research. 79:P4-13
Introduction: There is continuing debate whether efficacy of ET is different in non-visceral metastases (nVM) than VM. Recently fulvestrant 500mg, has been reported to have greater efficacy than an aromatase inhibitor (AI), anastrozole, particularly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::915036d9164e189fc79531e0255ea590
https://doi.org/10.1158/1538-7445.sabcs18-p4-13-11
https://doi.org/10.1158/1538-7445.sabcs18-p4-13-11
Autor:
V. Speirs, G. Viale, K. Mousa, C. Palmieri, S.N. Reed, H. Nicholas, M. Cheang, J. Jassem, P.E. Lønning, E. Kalaitzaki, C.J.H. van de Velde, B.B. Rasmussen, D.M. Verhoeven, A.M. Shaaban, J.M.S. Bartlett, J.M. Bliss, R.C. Coombes, A. Brociek, A. Pliszka, J. Andersen, B. Bruun Rasmussen, C. van de Velde, E. Meershoek, R. Paridaens, A. Delorge, A. Coates, R. Camler, S. Reed, D. Verhoeven, S. Herman, M. Visini, P. Lonning
Publikováno v:
Annals of Oncology
Intergroup Exemestane Study (IES) was a randomised study that showed a survival benefit of switching adjuvant endocrine therapy after 2-3 years from tamoxifen to exemestane. PathIES aimed to assess the potential prognostic and predictive value of ER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11d413f4fc14e06d80523193bb6d386b
https://pubmed.ncbi.nlm.nih.gov/26002610
https://pubmed.ncbi.nlm.nih.gov/26002610
Several papers dealing with the clinical relevance of steroid hormone receptors in breast cancer have already been published. However, no publication has overviewed studies currently being conducted in Europe, nor is there a register of the european
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J.G.M. Klijn, N. Rotmensz, R. Paridaens, R. Sylvester, A.T. van Oosterom, M. Bontenbal, H. T. Mouridsen, G. Cocconi, J. Wildiers, J. Jassem, M. Andersson
Publikováno v:
British Journal of Cancer, 77(12), 2257-2263. Nature Publishing Group
The EORTC Breast Cancer Cooperative Group carried out a randomized trial to compare doxorubicin with epirubicin as second-line chemotherapy in patients with metastatic breast cancer. Two hundred and fifty-nine patients with at least one site of metas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0576a1127311f4402415ed39cf11c9ba
https://doi.org/10.1038/bjc.1998.375
https://doi.org/10.1038/bjc.1998.375
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
R PARIDAENS, J HEUSON, J JULIEN, C VEYRET, J VANZIJL, J KLIJN, R SYLVESTER, F MIGNOLET, null EORTCBREASTCANCERCOOPERATIVEG
Publikováno v:
The Journal of Steroid Biochemistry and Molecular Biology. 37:1109-1113
We investigated whether estrogenic recruitment could enhance the antitumor effect of chemotherapy in 165 patients with advanced breast cancer, presumably sensitive to hormonal treatments (ER + and/or PgR + lesions). The therapeutic regimen consisted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22d4f993aa94fa570a7f61e1703cd747
https://doi.org/10.1016/0960-0760(90)90474-y
https://doi.org/10.1016/0960-0760(90)90474-y
Autor:
K, Boel, H, Van Poppel, H, Goethuys, J, Derluyn, F, Vandenbroucke, G, Popelier, J, Casselman, I, Billiet, L, Vanuytsel, R, Paridaens, L, Baert
Publikováno v:
Anticancer research. 19(3B)
Almost all patients that undergo hormonal manipulation for metastatic prostate cancer will ultimately progress because of hormone resistance. Therefore we assessed the effect of early addition of intravenous Mitomycin C to orchiectomy in patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b0da35177ca2629463d52a1b2071d853
https://pubmed.ncbi.nlm.nih.gov/10472324
https://pubmed.ncbi.nlm.nih.gov/10472324
Autor:
R. Paridaens, T. Beffort, P. Van Houtte, Christine Farvacques, Nicole Delvaux, Darius Razavi, Marianne Paesmans, Guy Leclercq
Publikováno v:
The Lancet. 335:931-933
Psychosocial correlates of hormone receptor status in primary breast cancers were investigated in 93 consecutive patients. Life event, coping style, and psychological adjustment self-report scales were completed. The 75 patients with receptor-positiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eab6e5447f5780f1152ed3b14dd6aa9f
https://doi.org/10.1016/0140-6736(90)90996-i
https://doi.org/10.1016/0140-6736(90)90996-i
Autor:
R, Paridaens
Publikováno v:
Seminars in oncology. 25(5 Suppl 12)
The anthracyclines are among the most active agents in the treatment of breast cancer. In recent years, the taxoids have produced promising results as single agents in breast cancer. Average overall response rates of 43% in previously untreated and 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2e9f176e921f7e47cabfba62207646a7
https://pubmed.ncbi.nlm.nih.gov/9865704
https://pubmed.ncbi.nlm.nih.gov/9865704